Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

The Role of Immune Dysfunction in Parkinson's Disease Development

* , , * ORCID logo
Version 1 : Received: 3 November 2023 / Approved: 6 November 2023 / Online: 6 November 2023 (11:09:33 CET)

A peer-reviewed article of this Preprint also exists.

Cossu, D.; Hatano, T.; Hattori, N. The Role of Immune Dysfunction in Parkinson’s Disease Development. Int. J. Mol. Sci. 2023, 24, 16766. Cossu, D.; Hatano, T.; Hattori, N. The Role of Immune Dysfunction in Parkinson’s Disease Development. Int. J. Mol. Sci. 2023, 24, 16766.

Abstract

Recent research has unveiled intriguing insights suggesting that the body's immune system may be implicated in Parkinson's disease (PD) development. Studies have observed disparities in pro-inflammatory and anti-inflammatory markers between PD patients and healthy individuals. This finding underscores the potential influence of immune system dysfunction in the genesis of this condition. A dysfunctional immune system can serve as a primary catalyst for systemic in-flammation in the body, which may contribute to the emergence of various brain disorders. The identification of several genes associated with PD, as well as their connection to neuroinflamma-tion, raises the likelihood of disease susceptibility. Moreover, advancing age and mitochondrial dysfunction can weaken the immune system, potentially implicating them in the onset of the dis-ease, particularly among older individuals. Compromised integrity of the blood-brain barrier could facilitate the immune system's access to brain tissue. This exposure may lead to encounters with native antigens or infections, potentially triggering an autoimmune response. Furthermore, there is mounting evidence supporting the notion that gut dysbiosis might represent an initial trigger for brain inflammation, ultimately promoting neurodegeneration. In this comprehensive review, we will delve into the numerous hypotheses surrounding the role of both innate and adaptive immunity in PD.

Keywords

Parkinson’s disease; immunity; neuroinflammation; mitochondria; dysbiosis; infections.

Subject

Medicine and Pharmacology, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.